Cargando…
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
A prominent feature of neurodegenerative diseases is synaptic dysfunction and spine loss as early signs of neurodegeneration. In this context, accumulation of misfolded proteins has been identified as one of the most common causes driving synaptic toxicity at excitatory glutamatergic synapses. In pa...
Autores principales: | Italia, Maria, Ferrari, Elena, Diluca, Monica, Gardoni, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313101/ https://www.ncbi.nlm.nih.gov/pubmed/35884851 http://dx.doi.org/10.3390/biomedicines10071550 |
Ejemplares similares
-
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
por: Ferrari, Elena, et al.
Publicado: (2023) -
Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice
por: Bigini, Paolo, et al.
Publicado: (2006) -
NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features
por: Gardoni, Fabrizio, et al.
Publicado: (2021) -
Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor Stimulation
por: Kobayashi, Shunsuke, et al.
Publicado: (2017) -
O-GlcNAcase Inhibitor ASN90 is a Multimodal
Drug Candidate for Tau and α-Synuclein Proteinopathies
por: Permanne, Bruno, et al.
Publicado: (2022)